title: Partnering with the NIH: Now part of the "Value Proposition" for start-ups.
abstract: With its "value proposition" statement a start-up company needs to convince potential investors or pharma partners how it will add more value or solve a problem better than others. High value, low cost assets such as those from the NIH ranging from technology to funding to assistance provide such biomedical firms an excellent jump-start in reaching their goals.
authors.affiliation: Office of Technology Transfer, National Institutes of Health, Department of Health and Human Services.
authors.forename: Steven M
authors.initials: SM
authors.lastname: Ferguson